3-(Trifluoromethoxy)aniline | CAS:1535-73-5

We serve 3-(Trifluoromethoxy)aniline CAS:1535-73-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(Trifluoromethoxy)aniline

Chemical Name:3-(Trifluoromethoxy)aniline
CAS.NO:1535-73-5
Synonyms:M-(TRIFLUOROMETHOXY)ANILINE; 
3-(trifluoromethyloxy)phenylaniline; 
α,α,α-Trifluoro-m-anisidine; 
3-Trifluoromethoxyaniline;
Molecular Formula:C7H6F3NO
Molecular Weight:177.12400
 
Physical and Chemical Properties:
Density:1.325;
Boiling point:72-73oC;
Flash point:185oF;
Index of Refraction:1.466;
 
Specification:
Appearance:Colourless to yellow to orange clear liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 3-(Trifluoromethoxy)aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Trifluoromethoxyaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(trifluoromethyloxy)phenylaniline Use and application,M-(TRIFLUOROMETHOXY)ANILINE technical grade,usp/ep/jp grade.


Related News: In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Triphenylmethyl Chloride manufacturer Delta said it will suspend flights between the United States and China starting on Sunday until at least April 30, according to a press release.N-((6-Chloropyridin-3-yl)methyl)ethanamine supplier According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.2-Bromo-5-fluoropyridine vendor According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.